Device type · OZP
Automated Insulin Dosing Device System, Single Hormonal Control
Last checked: Nov 19, 2026Source: openFDAMethods & limitations
Product code
OZP
Clinical Chemistry
Device class
Class III
FDA decisions since 2015
8
510(k), De Novo and PMA
Adverse event reports
121,744
Received Nov 1, 2025 to Nov 19, 2026
How FDA classifies it
- Device type
- Automated Insulin Dosing Device System, Single Hormonal Control
- Product code
- OZP
- Device class
- Class III
- Review panel
- Clinical Chemistry
- FDA record
- Classification database entry for OZP
Latest FDA decisions
- MiniMed 780G SystemPMA supplement
P160017-S125 · Decided Dec 11, 2025 · 225 days after receipt · Panel Track
Device type: Automated insulin dosing device system, single hormonal control (OZP) · Laboratory Medicine & Pathology
- MiniMed 780G SystemPMA supplement
P160017-S124 · Decided Aug 29, 2025 · 126 days after receipt · Panel Track
Device type: Automated insulin dosing device system, single hormonal control (OZP) · Laboratory Medicine & Pathology
- MiniMed 780G SystemPMA supplement
P160017-S118 · Decided Apr 18, 2025 · 368 days after receipt · Panel Track
Device type: Automated insulin dosing device system, single hormonal control (OZP) · Laboratory Medicine & Pathology
- MiniMed 780G SystemPMA supplement
P160017-S091 · Decided Apr 21, 2023 · 788 days after receipt · Panel Track
Device type: Automated insulin dosing device system, single hormonal control (OZP) · Laboratory Medicine & Pathology
- MiniMed 770G SystemBreakthroughPMA supplement
P160017-S076 · Decided Aug 31, 2020 · 304 days after receipt · Panel Track
Device type: Automated insulin dosing device system, single hormonal control (OZP) · Laboratory Medicine & Pathology
- MiniMed 670G SystemBreakthroughPMA supplement
P160017-S031 · Decided Jun 21, 2018 · 146 days after receipt · Panel Track
Device type: Automated insulin dosing device system, single hormonal control (OZP) · Laboratory Medicine & Pathology
- MiniMed 670G SystemPMA supplement
P160017-S017 · Decided Feb 13, 2018 · 195 days after receipt · Panel Track
Device type: Automated insulin dosing device system, single hormonal control (OZP) · Laboratory Medicine & Pathology
P160017 · Decided Sep 28, 2016 · 104 days after receipt
Device type: Automated insulin dosing device system, single hormonal control (OZP) · Laboratory Medicine & Pathology
Reports received
121,744
Received Nov 1, 2025 to Nov 19, 2026. Includes 7 of another or unstated type.
Malfunction reports
108,112
89% of reports
Injury reports
13,555
11% of reports
Death reports
70
0.1% of reports
Adverse event reports received per month
By the date FDA received each report, stacked by event type. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 7,116 | 1,279 | 15 | 0 |
| Jan 24 | 8,731 | 1,629 | 20 | 0 |
| Feb 24 | 8,634 | 1,036 | 23 | 0 |
| Mar 24 | 8,104 | 1,201 | 26 | 0 |
| Apr 24 | 7,611 | 841 | 17 | 0 |
| May 24 | 11,028 | 1,181 | 31 | 0 |
| Jun 24 | 8,053 | 1,183 | 25 | 0 |
| Jul 24 | 11,290 | 1,913 | 26 | 0 |
| Aug 24 | 10,055 | 1,166 | 18 | 0 |
| Sep 24 | 10,395 | 1,208 | 11 | 0 |
| Oct 24 | 9,258 | 1,202 | 9 | 0 |
| Nov 24 | 8,677 | 1,338 | 13 | 0 |
| Dec 24 | 12,142 | 1,477 | 20 | 0 |
| Jan 25 | 11,249 | 1,303 | 18 | 0 |
| Feb 25 | 6,342 | 794 | 5 | 0 |
| Mar 25 | 9,314 | 1,139 | 11 | 0 |
| Apr 25 | 11,793 | 1,344 | 16 | 0 |
| May 25 | 11,626 | 1,456 | 12 | 0 |
| Jun 25 | 9,729 | 1,417 | 14 | 0 |
| Jul 25 | 13,324 | 1,594 | 17 | 0 |
| Aug 25 | 12,320 | 1,445 | 12 | 0 |
| Sep 25 | 17,663 | 2,208 | 17 | 1 |
| Oct 25 | 11,896 | 1,680 | 14 | 0 |
| Nov 25 | 8,172 | 1,251 | 4 | 0 |
| Dec 25 | 12,151 | 1,609 | 9 | 0 |
| Jan 26 | 10,192 | 1,883 | 5 | 0 |
| Feb 26 | 11,717 | 2,121 | 13 | 0 |
| Mar 26 | 9,302 | 1,665 | 3 | 0 |
| Apr 26 | 8,846 | 1,499 | 9 | 0 |
| May 26 | 6,857 | 624 | 6 | 0 |
| Jun 26 | 8,026 | 665 | 4 | 0 |
| Jul 26 | 8,843 | 477 | 3 | 0 |
| Aug 26 | 6,918 | 536 | 4 | 7 |
| Sep 26 | 7,888 | 510 | 5 | 0 |
| Oct 26 | 9,200 | 715 | 5 | 0 |
| Nov 26 | 0 | 0 | 0 | 0 |
Manufacturers named most often
Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.
- Medtronic121,744
Device problems as coded
Last 12 months. FDA's terms. A report can carry several.
- Obstruction of Flow31,171
- Break14,267
- Key or Button Unresponsive/not Working12,626
- Battery Problem11,663
- Adverse Event Without Identified Device or Use Problem8,863
- Material Integrity Problem8,523
- Incorrect, Inadequate or Imprecise Result or Readings8,364
- Mechanical Problem7,514
- Power Problem6,026
- No Display/Image4,940
Patient problems as coded
Last 12 months. FDA's terms. A report can carry several.
- No Clinical Signs, Symptoms or Conditions91,608
- Hyperglycemia22,373
- Hypoglycemia7,827
- Hemorrhage/Blood Loss/Bleeding1,441
- Elevated Ketones/ Diabetic Ketoacidosis1,221
- Malaise810
- Fatigue428
- Vomiting418
- Loss of consciousness393
- Pain353
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
- MiniMed 670G Insulin Pump, Model: MMT-1781, MMT-1782;Open, Classified
Z-2981-2026 · Started Jul 13, 2026 · Posted by FDA Aug 18, 2026
Reason given: Loaner insulin pumps may have been cleaned with chemically incompatible products that could damage the pump case or keypad, allow moisture ingress, and result in insulin over- or under-delivery, potentially causing hypoglycemia, hyperglycemia, or diabetic ketoacidosis.
Cause as FDA categorized it: Process design
- MiniMed 670G Insulin Pump (MMT-1760, MMT-1761, MMT-1762, MMT-1780, MMT-1781, MMT-1782)Open, Classified
Z-1739-2026 · Started Feb 13, 2026 · Posted by FDA Apr 2, 2026
Reason given: All Medtronic MiniMed infusion pumps (Paradigm series, 600 series, and BLE 700 series) were found to be affected by unintended over- and under-delivery of insulin when the pump is elevated or lowered relative to the infusion site, respectively, because of changes in gravitational force impacting hydrostatic and...
Cause as FDA categorized it: Device Design
- MiniMed 770G Insulin Pump (MMT-1880, MMT-1881, MMT-1882, MMT-1890, MMT-1891, MMT-1892)Open, Classified
Z-1742-2026 · Started Feb 13, 2026 · Posted by FDA Apr 2, 2026
Reason given: All Medtronic MiniMed infusion pumps (Paradigm series, 600 series, and BLE 700 series) were found to be affected by unintended over- and under-delivery of insulin when the pump is elevated or lowered relative to the infusion site, respectively, because of changes in gravitational force impacting hydrostatic and...
Cause as FDA categorized it: Device Design
Z-1238-2026 · Started Nov 2, 2025 · Posted by FDA Feb 2, 2026
Reason given: A software timing and processor communication issue in MiniMed" 780G software version 6.60 may trigger Pump Error 43 and/or Pump Error 41, resulting in suspension of insulin delivery.
Cause as FDA categorized it: Process design
- MiniMed insulin pump, REF: 670G (MMT-1760, MMT-1761, MMT-1762, MMT-1780, MMT-1781, MMT-1782)Open, Classified
Z-1261-2025 · Started Jan 31, 2025 · Posted by FDA Mar 3, 2025
Reason given: All Medtronic MiniMed pumps (Paradigm series, Minimed 530G, 6XX series, and 7XX series) were found to have the potential for abnormal insulin delivery due to changes in air pressure, which can be found during airplane take-off or landing. An unexpected additional dose of insulin, which can occur during take-off, can...
Cause as FDA categorized it: Device Design
Z-1262-2025 · Started Jan 31, 2025 · Posted by FDA Mar 3, 2025
Reason given: All Medtronic MiniMed pumps (Paradigm series, Minimed 530G, 6XX series, and 7XX series) were found to have the potential for abnormal insulin delivery due to changes in air pressure, which can be found during airplane take-off or landing. An unexpected additional dose of insulin, which can occur during take-off, can...
Cause as FDA categorized it: Device Design
- MiniMed insulin pump, REF: 770G (MMT-1880, MMT-1881, MMT-1882, MMT-1890, MMT-1891, MMT-1892)Open, Classified
Z-1265-2025 · Started Jan 31, 2025 · Posted by FDA Mar 3, 2025
Reason given: All Medtronic MiniMed pumps (Paradigm series, Minimed 530G, 6XX series, and 7XX series) were found to have the potential for abnormal insulin delivery due to changes in air pressure, which can be found during airplane take-off or landing. An unexpected additional dose of insulin, which can occur during take-off, can...
Cause as FDA categorized it: Device Design
- MiniMed insulin pump, REF: 780G (MMT-1884, MMT-1885, MMT-1886, MMT-1894, MMT-1895, MMT-1896)Open, Classified
Z-1266-2025 · Started Jan 31, 2025 · Posted by FDA Mar 3, 2025
Reason given: All Medtronic MiniMed pumps (Paradigm series, Minimed 530G, 6XX series, and 7XX series) were found to have the potential for abnormal insulin delivery due to changes in air pressure, which can be found during airplane take-off or landing. An unexpected additional dose of insulin, which can occur during take-off, can...
Cause as FDA categorized it: Device Design
Showing the 8 newest of 23 recall records in FDA's data.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.